Alicuben ET, Samaan JS, Houghton CC, Soffer E, Lipham JC, Samakar K (2021) Sleeve gastrectomy as a novel procedure for gastroparesis
Additionally, the injectable nature of many GLP-1 drugs still poses a barrier for patient acceptance in certain demographics, although oral versions are addressing this gap
Novo Nordisk has launched its own telehealth programme for regular-dose semaglutide through its own channels, as well as other providers, for $499 per month, although a partnership with Hims & Hers quickly broke down due to what the company said were "concerns about [] illegal mass compounding and deceptive marketing." Hims & Hers which accused Novo Nordisk of 'anticompetitive' actions is now offering a compounded version at $199 per month.
One difference noted in clinical trials: oral semaglutide patients reported excessive belching more frequently (14% vs
The CIO ORBIE Awards is the premier technology executive recognition program of its kind that recognizes CIOs in Georgia who have shown excellence in technology leadership